A paradigm shift to prevent HIV drug resistance
- PMID: 18494556
- PMCID: PMC2386833
- DOI: 10.1371/journal.pmed.0050111
A paradigm shift to prevent HIV drug resistance
Abstract
David Bangsberg discusses a new observational cohort study in nine countries in southern Africa that compares CD4 counts versus adherence to antiretroviral drugs for predicting virologic failure.
Conflict of interest statement
Comment on
-
Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.PLoS Med. 2008 May 20;5(5):e109. doi: 10.1371/journal.pmed.0050109. PLoS Med. 2008. PMID: 18494555 Free PMC article.
References
-
- World Health Organization. Management of HIV Infection and Antiretroviral Therapy in Adults and Adolescents. A Clinical Manual. 2007. Available: http://www.searo.who.int/LinkFiles/Publications_Management_HIV_infection.... Accessed 8 April 2008.
-
- Calmy A, Ford N, Hirschel B, Reynolds SJ, Lynen L, et al. HIV viral load monitoring in resource-limited regions: Optional or necessary. Clin Infect Dis. 2007;44:128–134. - PubMed
-
- Bisson GP, Gross R, Bellamy S, Chittams J, Hislop M, et al. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy. PLoS Med. 2008;5:e109. doi: 10.1371/journal.pmed.0050109. - DOI - PMC - PubMed
-
- Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis. 2002;34:1115–1121. - PubMed
-
- Liu H, Miller LG, Hays RD, Golin CE, Wu T, et al. Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors. J Acquir Immune Defic Syndr. 2006;41:315–322. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
